Poster

RAS/RAF mutation status in Algerian patients with metastatic colorectal cancer (mCRC) and impact of the primary site on clinical and prognostic outcomes

BackgroundRAS/RAF mutation status is a major molecular outcome in colorectal cancer (CRC), and these mutations have been suggested as predictive and prognostic biomarkers. Previous report...

06/25/2023

Inflammatory status as a predictor of resectability in borderline resectable pancreatic cancer

BackgroundThe incidence of pancreatic cancer (PC) has been increasing and continues to be associated with a high mortality rate. Surgical resection is the only curative option. About 15% ...

06/25/2023

Insights of the prevalence of KRAS mutations in a real life population cohort of colorectal cancer based in north of Portugal

BackgroundColorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new cases every year. In Portugal, recent data have shown that colorectal cancer was the most...

06/25/2023

Total neoadjuvant treatment of rectal cancer by MRI-guided radiotherapy

BackgroundShort-course radiotherapy (5 x 5 Gy) followed by chemotherapy before total mesorectal excision (TME) decreased the probability of disease-related treatment failure and became th...

06/25/2023

Perioperative FLOT in locally advanced and gastroesophageal junction cancer: A real-word experience in Argentina

BackgroundGastric cancer is a disease with a high mortality rate, even in early stages. The combination of surgery with perioperative systemic treatment with the FLOT regimen, based on fl...

M. Aymar ;

I. Basbus ;

M. Gornatti ;

D. Bradley Gomez ;

06/25/2023

CoVigi phase IV multicentric trial evaluating COVID-19 vaccination effectiveness, safety, and immune response dynamics: SARS-CoV-2-specific antibody and T-cell response focused on patients with gastrointestinal tumors

BackgroundSolid cancer patients are at high risk of a more severe course of COVID-19, especially those undergoing active anti-cancer therapy causing immunosuppression. Vaccination is stil...

06/25/2023

Prognostic stratification of TAS-102 treatment

BackgroundIn metastatic colorectal cancer (mCRC) the choice of treatment should take into account the characteristics of the tumor and the patient, as well as its efficacy and tolerabilit...

06/25/2023

The frequency and pattern of metachronous recurrence after endoscopic submucosal dissection for dysplasias and adenocarcinoma of stomach

BackgroundMetachronous recurrence incidences and risk factors following endoscopic submucosal dissection (ESD) for gastric adenocarcinoma and dysplasias were investigated. ...

06/25/2023

Efficacacy of trifluridine/tipiracil according to extended RAS evaluation: A multicenter retrospective analysis

BackgroundTrifluridine/tipiracil (TAS102) has been shown to improve survival in later lines of treatment of metastatic colorectal cancer patients, irrespective of RAS status. This study a...

06/25/2023

Association of vascular endothelial growth factor gene polymorphisms with esophageal squamous cell cancer risk in North-West Indians: A case-control study

BackgroundVascular endothelial growth factor (VEGF) is a crucial regulator of physiological and pathological angiogenesis. Increased VEGF expression has been linked with inappropriate VEG...

06/25/2023